Clinical Trials Logo

Filter by:
NCT ID: NCT03292575 Completed - Stroke Clinical Trials

Study of the Follow-up of Stroke Treated With Anticoagulants

AOD
Start date: January 2016
Phase:
Study type: Observational

Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). Ischemic cardio-embolic stroke accounts for around 25% of ischemic strokes, and ischemic cardio-embolic stroke in a context of cardiac arrhythmia due to atrial fibrillation (CAAF) is the leading non-atheromatous cause. The aim of this study is to optimise the secondary prevention of CAAF-related stroke identified at the University Hospital of Dijon Burgundy in the framework of the recommendations of the '2010-2014 stroke plan' and the Compulsory Consultation at the 6th month (Directive DGOS//2015/262 of the 3rd August 2015)

NCT ID: NCT03292549 Completed - Kidney Cancer Clinical Trials

RObotic PArtial Nephrectomy National Study

ROPAN
Start date: April 2014
Phase: N/A
Study type: Observational

The purpose of the study is to set up the larger prospective study on robotic partial nephrectomy, to describe the characteristics of patients operated for kidney cancer by this surgical procedure and also to determine the modalities of hemostasis in this procedure.

NCT ID: NCT03292523 Completed - Clinical trials for Hyperventilation Syndrome

Work Productivity in Hyperventilation Syndrome

WHY
Start date: February 6, 2018
Phase:
Study type: Observational

Hyperventilation syndrome is associated with impaired quality of life. The aim of the study is to assess the relationship between work productivity, including absenteeism and presenteeism, and the severity of hyperventilation syndrome

NCT ID: NCT03292484 Completed - Peanut Allergy Clinical Trials

Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

Start date: October 11, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess AR101's safety, tolerability and efficacy over an extended dosing period.

NCT ID: NCT03292406 Completed - Clinical trials for Cutaneous T Cell Lymphoma

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

CTCL
Start date: December 19, 2017
Phase: Phase 2
Study type: Interventional

To assess the efficacy, safety and pharmacokinetics in participants treated with CD11301 gel vs. placebo for early stage CTCL (IA, IB, or IIA).

NCT ID: NCT03292120 Completed - Septic Shock Clinical Trials

Venous to Arterial Carbon Dioxide Difference (P₍ᵥ₋ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂

Start date: June 2016
Phase: N/A
Study type: Interventional

the investigators will include 120 patients with a diagnosis of septic shock in accordance with the definition given by the 2001 expert consensus. Two groups of patients are likely to participate in this study: Patient hospitalized in intensive care for a septic shock = Primary patient + patient who develops, the waning of his hospitalization in intensive care for another reason, a septic shock = Secondary patient. Haemodynamic monitoring by transpulmonary thermodilution allow a patient's close monitoring during the initial phase supported. The clinical and biological data, demographic and the severity scores are collected for each patient during the first three days of stay. To predict the unfavorable evolution of the patients, a measure of the SOFA score at the input (J0) and third day (J2) is performed. the investigators analyzed mortality at day 28 in patients with increased P₍ᵥ₋ₐ₎CO₂ and those with increasing of organ failure. This research will be conducted according to good clinical practice. An information will be distributed to patients.

NCT ID: NCT03291977 Completed - Glioblastoma, Adult Clinical Trials

Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)

FLEGME
Start date: October 5, 2017
Phase: Phase 3
Study type: Interventional

Fluorescence guidance is a safe and efficient tool for glioblastomas resection. The most widely used technique is based on 5-aminolevulinic acid (5ala), which stains glioblastoma cells through a metabolic abnormality and thus helps in defining tumoral edges through a modified microscope. A multicentric, randomized study comparing 5ala guided surgery with conventional procedures showed that this technique doubles the rate of complete removal on post-operative magnetic resonance imaging (MRI), and increases the 6 months progression-free survival. More recently, fluorescein appeared as an interesting alternative fluorophore for glioblastomas, with a highly reduced cost (2.5 euros versus 1000 euros per dose). However its use remains scarcely studied and its clinical benefit unsure. In that context, the investigators propose a randomized trial comparing conventional " white light " surgery with fluorescein-guided resection of glioblastomas, in order to assess the relevance of this technique in glioblastomas removal.

NCT ID: NCT03290989 Completed - Skin Cancer Clinical Trials

Itch and Pain Characteristics in Skin Carcinomas

PRURITCC
Start date: April 1, 2015
Phase: N/A
Study type: Observational

The objective of this study is to have better knowledge about sensations of patients with skin carcinomas and to have data about characteristics of pain and pruritus . All patients presenting with a suspicions lesion for skin carcinomas will be included and will respond to a questionnaire. Demographics data, and histological data about skin carcinomas will be collected.

NCT ID: NCT03290885 Completed - Clinical trials for Acute Ischemic Stroke

Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction

ASTER2
Start date: October 16, 2017
Phase: N/A
Study type: Interventional

Mechanical thrombectomy (MT) with a stent retriever (SR) device is now the standard intervention in ischemic stroke with large vessel occlusion. Favorable outcome is strongly associated with the successful reperfusion status. New device of MT such as contact aspiration seems promising to increase reperfusion status and clinical outcome. The main hypothesis is to show the superiority of combining the use of contact aspiration with a stent retriever compared to a stent retriever alone in treatment of acute stroke due to proximal arterial occlusion. The primary endpoint is the rate of perfect reperfusion score at the end of the endovascular procedure.

NCT ID: NCT03290755 Completed - Hepatitis c Clinical Trials

Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux

HEPCSEX
Start date: November 8, 2017
Phase:
Study type: Observational

The main objective of this study is to analyse sexual behavior of HIV + MSM in Bordeaux, who have sexually contracted hepatitis C between January 1st 2013, to January 31, 2017. These data will bring some improvement about prevention and maybe reduced the hepatitis C incidence.